Multi-STEM MePCR: a bisulfite-free, multiplex, highly sensitive and highly specific assay to measure DNA methylation

Area of Science:

• Epigenetics
• Molecular Biology
• Cancer Diagnostics

Background:

• Aberrant CpG island methylation is a key biomarker in cancer diagnosis.
• Existing methods for multiplexed methylation analysis are often inefficient and complex.
• Standard PCR platforms have limitations for comprehensive methylation profiling.

Purpose of the Study:

• To develop an innovative, bisulfite-free, multiplex assay for genomic methylation analysis.
• To enable simultaneous detection of multiple CpG sites with high sensitivity and specificity.
• To provide a simpler, faster, and more cost-effective alternative to current techniques.

Main Methods:

• Developed a novel multiplex assay: multiple specific terminal mediated methylation PCR (multi-STEM MePCR).
• Integrated a methylation-dependent restriction endonuclease (MDRE) with multiplex PCR.
• Utilized stem-loop structured assays for simultaneous detection of multiple CpG sites.

Main Results:

• Achieved quantification of three methylation model sites down to ten copies per tube.
• Demonstrated a sensitivity of 0.1% against a large background of unmethylated DNA.
• Showcased minimized cross-reactivity and target competition, enabling precise methylation abundance distinction.

Conclusions:

• The multi-STEM MePCR platform offers high clinical precision comparable to bisulfite sequencing.
• This technology provides a simpler, faster, and lower-cost solution for multiplexed methylation analysis.
• Pioneers an advanced strategy essential for epigenetic research and clinical DNA methylation diagnostics.